Abstract | AIM: MATERIALS AND METHODS: Eighty-nine patients with peri-implant mucositis were included in a double-blinded, randomized, placebo-controlled trial with mechanical debridement and 1-month use of either delmopinol, chlorhexidine (CHX), or a placebo mouthrinse. Submucosal and subgingival plaque samples of implants and teeth were collected at baseline and after 1 and 3 months, processed for 16S V4 rRNA gene amplicon sequencing, and analysed bioinformatically. RESULTS: The sites with peri-implant mucositis presented with a less diverse and less anaerobic microbiome. Exposure to delmopinol or CHX, but not to the placebo mouthrinse resulted in microbial changes after 1 month. The healthy sites around the teeth harboured a more diverse and more anaerobe-rich microbiome than the healthy sites around the implants. CONCLUSIONS: Peri-implant sites with mucositis harbour ecologically less complex and less anaerobic biofilms with lower biomass than patient-matched dental sites with gingivitis while eliciting an equal inflammatory response. Adjunctive antimicrobial therapy in addition to mechanical debridement does affect both dental and peri-implant biofilm composition in the short term, resulting in a less dysbiotic subgingival biofilm.
|
Authors | Juliana Philip, Mark J Buijs, Vincent Y Pappalardo, Wim Crielaard, Bernd W Brandt, Egija Zaura |
Journal | Journal of clinical periodontology
(J Clin Periodontol)
Vol. 49
Issue 1
Pg. 28-38
(01 2022)
ISSN: 1600-051X [Electronic] United States |
PMID | 34664294
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 The Authors. Journal of Clinical Periodontology published by John Wiley & Sons Ltd. |
Chemical References |
|
Topics |
- Dental Implants
(adverse effects)
- Dental Plaque
- Humans
- Microbiota
- Mucositis
- Peri-Implantitis
(therapy)
|